Department of visceral and digestive surgery, Louis Mourier hospital, APHP
Colombes, 92025, France
Location status: Recruiting
NCT Number: NCT05488288
The primary objective of the study is to demonstrate that hernia recurrence (VH) repair with non absorbable mesh concomitant to Bariatric Surgery (BS) decreases the risk of VH, with or without surgical repair, during the first two years after BS when compared to VH suture repair without mesh.
As secondary objectives, the study aims to assess the impact of concomitant VH repair with non absorbable mesh versus suture repair in morbidly obese BS candidates on the following measures: - hernia recurrence at 1 year after randomization; - reoperation for hernia recurrence at 2 years after randomization; - strangulated hernia, surgical infection and mesh bulging at one year after randomization; - postoperative morbidity and mortality at 90 days after randomization; - benefit-risk ratio; - chronic pain at three months, six months, one year and two years after randomization; - quality of life during the two years after randomization; - incremental cost utility ratio; - short- and mid-term weight loss. To study if the efficacy of mesh versus suture VH repair differs according to the type and size of VH and to the surgical technique.
Interested in participating?
Request Info18 year–60 year
All sexes
Interventional
Phase 3
Colombes, 92025, France
Location status: Recruiting
This is a prospective, multicentric, superiority, comparative randomized (1:1) single-blinded clinical trial with blinded assessment of the primary endpoint.
Hypothesis for the study: abdominal ventral hernia (VH) repair with mesh during bariatric surgery (BS) is more effective than suture repair in preventing VH recurrence. Secondarily, we expect that mesh repair would not increase the risk of surgical site infection.
Population of study participants:
Patients between 18 and 60 years, presenting with VH and scheduled for BS, excluding pregnant women and protected adults.
All consecutive eligible patients will be invited to participate by visceral surgeons during preoperative consultations for BS. Included patients will be randomly assigned (1/1 ratio) to either mesh VH repair (intervention group) or suture VH repair (control group) by visceral surgeons at hospital admission (hospitalization or outpatient surgery) for BS and VH repair.
Patients will be followed according to clinical guidelines for BS follow-up at M1, M3, M6, M9, M12, M18 and M24 after BS.
There will be 29 surgical centers in France (digestive surgeons), targetting 354 eligible patients.
Statistical analysis:
An intention-to-treat statistical analysis will be performed at the end of the follow-up, when primary endpoint of all randomized patients will be documented.
The analysis for the primary endpoint will consist in comparing proportions of hernia recurrence during the two years after surgery between the two arms, using a Chi2 test.
An interim analysis is planned after half of the subjects finished their follow-up, in order to confirm the efficacy of the intervention arm, or alternatively its lack of efficacy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Abdominal ventral hernia (VH) repair with mesh during bariatric surgery. the repair technique and the type of mesh are left to the choice of the center, as there are no strong data to demonstrate which technique is the best for VH repair in this population.
The hernia sack is resected through an open approach, and the fascial defect is systematically closed with a slowly absorbable monofilament suture.
Time frame: at 2 years
Final diagnosis of hernia recurrence will be made by an endpoint committee of radiologists, blinded to the randomization arm (it is not possible to distinguish mesh from suture repair on CT-scans) on abdomino-pelvic CT-scan without contrast injection.
Radiological hernia is defined as any protrusion of abdominal contents, including the anterior parietal peritoneum, visible as discontinuity of the fascial layers.
In case of hernia recurrence requiring new VH repair during the study period (before the two years CT-scan evaluation), this will be considered as an event in intention-to-treat analysis.
Time frame: at 1 year
Hernia recurrence rate clinically
Time frame: at 2 years
Reoperation rate for recurrence, at 2 years after randomization with medical files.
Time frame: at 1 year
Strangulated hernia rate (requiring emergent surgery), at 1 year after randomization (medical files)
Time frame: at 1 year
Surgical site infection rate (superficial or deep), at 1 year after randomization (medical files)
Time frame: at 2 years
Mesh bulging rate, defined by a protrusion of the mesh through a fascial defect without hernia recurrence at CT-scan evaluation, at 2 years after randomization.
Time frame: daily up to 90 days
Postoperative morbidity rate (any complication in the 90 days after randomization).
Time frame: daily up to 90 days
Postoperative mortality rate (any complication in the 90 days after randomization).
Time frame: at the end of the study
Benefit-risk ratio (DOOR-RADAR score established by the scientific committee prior to the start of the study).
Time frame: at 3 months, 6 months, 1 year and 2 years
Self-reported chronic pain, using the Visual Analogue Scale, at 3 months, 6 months, 1 year and 2 years after randomization
Time frame: at 3 months, 6 months, 1 year and 2 years
Using the EQ-5D-5L self-questionnaire EuroQol-5Dimensions-5Levels self-questionnaire (EQ-5D-5L value : -0.530 to 1.0 ; 1.0 indicates the best quality of life)
Time frame: at 3 months, 6 months, 1 year and 2 years
Using Visual Analogue Scale Visual Analogue Scale (0 to100; 0 represents 'no pain at all' whereas 100 represents 'the worst pain ever possible')
Time frame: at 2 years
Cost will be calculated.
Time frame: at 3 months, 6 months, 1 year and 2 years
Short-term weight loss (percentage of excess weight loss at 3 and 6 months after the procedure); mid-term weight loss (percentage of excess weight loss at 1 and 2 years after the procedure).
Time frame: at 2 years
Hernia recurrence rate at 2 years after randomization, by type (primary or incisional) and size of VH and by surgical technique (sublay/retromuscular or intraperitoneal or preperitoneal/underlay).
Contact information is provided by the study sponsor or research team.
Assistance Publique - Hôpitaux de Paris
Other
Acronym: BeSURE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06611462
Alcohol Drinking, Behavior
Herlev, Denmark
View Trial DetailsNCT05797974
Body Weight, Hernia
Jacksonville, Florida, United States
View Trial DetailsNCT06367309
Abdominal Wall Defect, Hernia
Basel, Canton of Basel-City, Switzerland
View Trial DetailsNCT06364306
Abdominal Wall Defect, Hernia
Kempten (Allgäu), Bavaria, Germany
View Trial Details